These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36035923)

  • 41. Easy prognostic assessment of concomitant organ failure in critically ill patients undergoing mechanical ventilation.
    Wernly B; Frutos-Vivar F; Peñuelas O; Raymondos K; Muriel A; Du B; Thille AW; Ríos F; González M; Del-Sorbo L; Del Carmen Marín M; Pinheiro BV; Soares MA; Nin N; Maggiore SM; Bersten A; Kelm M; Amin P; Cakar N; Lichtenauer M; Suh GY; Abroug F; Jibaja M; Matamis D; Zeggwagh AA; Sutherasan Y; Anzueto A; Esteban A; Jung C
    Eur J Intern Med; 2019 Dec; 70():18-23. PubMed ID: 31606309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.
    Egbe AC; Miranda WR; Dearani J; Kamath PS; Connolly HM
    J Am Coll Cardiol; 2020 Dec; 76(25):2968-2976. PubMed ID: 33334426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    Amdani S; Simpson KE; Thrush P; Shih R; Simmonds J; Knecht K; Mogul DB; Hurley K; Koehl D; Cantor R; Naftel D; Kirklin JK; Daly KP
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1462-1473.e12. PubMed ID: 33745714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].
    Boin Ide F; Leonardi MI; Udo EY; Sevá-Pereira T; Stucchi RS; Leonardi LS
    Arq Gastroenterol; 2008; 45(4):275-83. PubMed ID: 19148354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants and Prognostic Implications of Hepatorenal Dysfunction in Adults With Congenital Heart Disease.
    Egbe AC; Miranda WR; Anderson JH; Katta RR; Goda AY; Andi K; Kamath PS; Connolly HM
    Can J Cardiol; 2022 Nov; 38(11):1742-1750. PubMed ID: 35934261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.
    He SJ; Weng JX; Chen HJ; Li HQ; Guo WQ; Cao Q; Xu S; Yan HB; Peng CN
    BMC Cardiovasc Disord; 2021 Jan; 21(1):53. PubMed ID: 33509076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair.
    Tanaka T; Kavsur R; Sugiura A; Vogelhuber J; Öztürk C; Weber M; Tiyerili V; Zimmer S; Nickenig G; Becher MU
    Sci Rep; 2021 Jul; 11(1):14420. PubMed ID: 34257395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
    Kim MS; Kato TS; Farr M; Wu C; Givens RC; Collado E; Mancini DM; Schulze PC
    J Am Coll Cardiol; 2013 Jun; 61(22):2253-2261. PubMed ID: 23563127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
    Okano T; Motoki H; Minamisawa M; Kimura K; Kanai M; Yoshie K; Higuchi S; Saigusa T; Ebisawa S; Okada A; Shoda M; Kuwahara K
    PLoS One; 2020; 15(10):e0241003. PubMed ID: 33095810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation.
    Lv J; Ye Y; Li Z; Zhang B; Liu Q; Zhao Q; Zhao Z; Wang W; Zhang H; Duan Z; Wang B; Yu Z; Guo S; Zhao Y; Gao R; Xu H; Wu Y;
    Eur Heart J Qual Care Clin Outcomes; 2023 Apr; 9(3):227-239. PubMed ID: 35612991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thinking fast and slow: lactate and MELD-XI (model for end-stage liver disease excluding INR) are useful for estimating mortality after cardiopulmonary resuscitation.
    Rezar R; Lichtenauer M; Schwaiger P; Seelmaier C; Pretsch I; Ausserwinkler M; Reichle J; Jirak P; Jung C; Strohmer B; Hoppe UC; Wernly B
    Minerva Anestesiol; 2021 Sep; 87(9):1017-1024. PubMed ID: 33938680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modified model for end-stage liver disease score predicts 30-day mortality in high-risk patients with acute pulmonary embolism admitted to intensive care units.
    İdin K; Dereli S; Kaya A; Yenerçağ M; Yılmaz AS; Tayfur K; Gülcü O
    Scand Cardiovasc J; 2021 Aug; 55(4):237-244. PubMed ID: 33491501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Model for end-stage liver disease combined with arterial blood lactate to assess the prognosis of hepatitis B virus-associated acute-on-chronic liver failure: a retrospective analysis of 97 cases].
    Yao YH; Zhao WF; Gan JH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):256-260. PubMed ID: 31082335
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].
    Zhou Q; Tan D; Yi Z; Zheng Y; Lu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on the application value of MELD-Na, CLIF-C OFs, COSSH-ACLFs and NLR scoring systems in patients with hepatitis B virus related acute-on-chronic liver failure].
    Miao J; Guo L; Wang L; Cui H; Li Q; Wang J; Zhu B; Jia J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1496-1501. PubMed ID: 33541504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
    Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
    Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.
    Remmler J; Schneider C; Treuner-Kaueroff T; Bartels M; Seehofer D; Scholz M; Berg T; Kaiser T
    Clin Gastroenterol Hepatol; 2018 May; 16(5):730-737. PubMed ID: 28919544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.